330
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Choroidal and Retinal Anatomical Responses Following Systemic Corticosteroid Therapy in Vogt–Koyanagi–Harada Disease Using Swept-Source Optical Coherence Tomography

, BS OPTOMETRY, , MS, , MS, , MSC, , MS, , MD, , DNB & , MS show all
Pages 235-243 | Received 05 Jan 2017, Accepted 15 May 2017, Published online: 12 Jul 2017

REFERENCES

  • Sakata VM, da Silva FT, Hirata CE, et al. Diagnosis and classification of Vogt–Koyanagi–Harada disease. Autoimmun Rev. 2014;13(4):550–555.
  • Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39(4):265–292.
  • Rao NA, Gupta A, Dustin L, et al. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology. 2010;117(3):591–599.
  • Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: Report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647–652.
  • Nakayama M, Keino H, Okada AA, et al. Enhanced depth imaging optical coherence tomography of the choroid in Vogt–Koyanagi–Harada disease. Retina. 2012;32(10):2061–2069.
  • Hosoda Y, Hayashi H, Kuriyama S. Posterior subtenon triamcinolone acetonide injection as a primary treatment in eyes with acute Vogt–Koyanagi–Harada disease. Br J Ophthalmol. 2015;99(9):1211–1214.
  • Hirooka K, Saito W, Namba K, et al. Significant role of the choroidal outer layer during recovery from choroidal thickening in Vogt-Koyanagi-Harada disease patients treated with systemic corticosteroids. BMC Ophthalmol. 2015;15(1):1.
  • Gallagher MJ, Yilmaz T, Cervantes-Castañeda RA, et al. The characteristic features of optical coherence tomography in posterior uveitis. Br J Ophthalmol. 2007;91(12):1680–1685.
  • Agrawal R, Salman M, Tan KA, et al. Choroidal Vascularity Index (CVI): A novel optical coherence tomography parameter for monitoring patients with panuveitis? PloS One. 2016;11(1):e0146344.
  • Spaide RF, Koizumi H, Pozonni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146(4):496–500.
  • Agrawal R, Li LK, Nakhate V, et al. Choroidal Vascularity Index in Vogt-Koyanagi-Harada disease: An EDI-OCT derived tool for monitoring disease progression. Transl Vis Sci Technol. 2016;5(4):7.
  • Drexler W, Fujimoto JG. State-of-the-art retinal optical coherence tomography. Prog Ret Eye Res. 2008;27(1):45–88.
  • Regatieri CV, Branchini L, Fujimoto JG, et al. Choroidal imaging using spectral-domain optical coherence tomography. Retina. 2012;32(5):865–876.
  • Huang TL, Huang SP, Chang CH, et al. Protective effects of systemic treatment with methylprednisolone in a rodent model of non-arteritic anterior ischemic optic neuropathy (rAION). Exp Eye Res. 2015;131:69–76.
  • Nakai K, Gomi F, Ikuno Y, et al. Choroidal observations in Vogt–Koyanagi–Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2012;250(7):1089–1095.
  • Fong AH, Li KK, Wong D. Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt–Koyanagi–Harada disease. Retina. 2011;31(3):502–509.
  • Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of Vogt–Koyanagi–Harada disease. Retina. 2011;31(3):510–517.
  • Motaghiannezam R, Schwartz DM, Fraser SE. In vivo human choroidal vascular pattern visualization using high-speed swept-source optical coherence tomography at 1060 nm SS-OCT visualization of human choroidal vascular pattern. Investig Ophthalmol Vis Sci. 2012;53(4):2337–2348.
  • Copete S, Flores-Moreno I, Montero JA, et al. Direct comparison of spectral-domain and swept-source OCT in the measurement of choroidal thickness in normal eyes. Br J Ophthalmol. 2014;98(3):334–338.
  • Adhi M, Liu JJ, Qavi AH, et al. Enhanced visualization of the choroido-scleral interface using swept-source OCT. Ophthalmic Surg Lasers Imaging Retina. 2013;44(6):S40–S42.
  • Sonoda S, Sakamoto T, Yamashita T, et al. Luminal and stromal areas of choroid determined by binarization method of optical coherence tomographic images. American journal of ophthalmology. 2015;159(6):1123–1131.
  • Nazari H, Hariri A, Hu Z, et al. Choroidal atrophy and loss of choriocapillaris in convalescent stage of Vogt-Koyanagi-Harada disease: in vivo documentation. J Ophthalmic Inflamm Infect. 2014;4(1):1.
  • Bittencourt MG, Kherani S, Ferraz DA, et al. Variation of choroidal thickness and vessel diameter in patients with posterior non-infectious uveitis. J Ophthalmic Inflamm Infect. 2014;4(1):1.
  • Hirose S, Saito W, Yoshida K, et al. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt–Koyanagi–Harada disease. Acta Ophthalmol. 2008;86(8):902–907.
  • Chan WM, Lam DS, Lai TY, et al. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol. 2003;87(12):1453–1458.
  • Hosoda Y, Uji A, Hangai M, et al. Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2014;157(5):1056–1063.
  • Yamamoto M, Nishijima K, Nakamura M, et al. Inner retinal changes in acute-phase Vogt-Koyanagi-Harada disease measured by enhanced spectral domain optical coherence tomography. Jpn J Ophthalmol. 2011;55(1):1–6.
  • Mawatari Y, Hirata A, Fukushima M, et al. Choroidal dye filling velocity in patients with Vogt–Koyanagi–Harada disease. Graefes Arch Clin Exp Ophthalmol. 2006;244(8):1056–1059.
  • Nakao K, Abematsu N, Mizushima Y, et al. Optic disc swelling in Vogt-Koyanagi-Harada disease optic disc swelling in VKH. Investig Ophthalmol Vis Sci. 2012;53(4):1917–1922.
  • Din NM, Taylor SR, Isa H, et al. Evaluation of retinal nerve fiber layer thickness in eyes with hypertensive uveitis. JAMA Ophthalmol. 2014;132(7):859–865.
  • Shah SM, Sepah Y, Sadiq M, et al. Segmentation and analysis of retinal layers in eyes with uveitis and comparison with normal. Investig Ophthalmol Vis Sci. 2013;54(15):5205.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.